PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328966
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328966
In 2022, the European market for dental implants and final abutments was valued at almost €1.2 billion. This is projected to grow at a CAGR of 4.1% during the forecast period, reaching just above €1.5 billion. Key players in the European dental implant market include Straumann Group, Dentsply Sirona, and Envista. Our comprehensive research involved the analysis of over 60 dental implant companies in Europe, enabling us to accurately gauge market sizes, unit sales, company market shares, and create precise forecasts.
Historically, the European dental implant market has been largely dominated by premium implant companies. However, a shift is underway as patients and dental professionals become more cost-conscious, showing increased interest in discounted and value implant products. This transition varies across Europe, yet the combined market share of value and discount segments is predicted to account for over half of the total dental implant market value by the forecast period's end.
Demographics play a crucial role in driving the dental implant and final abutment market. The aging population significantly fuels the demand for dental treatments. By 2030, individuals aged 65 and above are expected to make up 25% of the total population. Coupled with this, the European region reported the highest prevalence of major oral diseases in 2019, affecting nearly 50% of the adult population.
In 2022, the European dental implant and final abutment market saw Straumann Group emerge as the dominant player, commanding the largest share. This leadership stems from its robust presence in both dental implant and final abutment sectors, alongside its notable contributions in treatment planning software and surgical guide segments. Straumann Group's success is underpinned by its comprehensive product portfolio, encompassing traditional and innovative solutions, including ceramic implants, full-arch restorations, CAD/CAM abutments, and regenerative dental biomaterials. Dentsply Sirona claimed the second spot, excelling in dental implant and final abutment markets, while leading in treatment planning software and surgical guide segments, reinforced by their expertise in CAD/CAM abutments. Envista secured the third rank, capitalizing on technological breakthroughs in dental implantology through its Nobel Biocare brand, a pioneer of the groundbreaking All-on-4® treatment concept.
List of Charts
List of Figures